Covered recipient · General Payments record
AME PHITWONG
Allopathic & Osteopathic Physicians Dermatology
General Payments · PY2021–2024
$1,279.57
- Reported across 31 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $520.91 | 17 |
| Education | $99.00 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $257.77 | 10 |
| Janssen Biotech, Inc. | $137.60 | 5 |
| Lilly USA, LLC | $94.55 | 1 |
| UCB, Inc. | $78.02 | 1 |
| Dermavant Sciences, Inc. | $51.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.36 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848451 | CMS |
| ABBVIE INC. | $91.50 | 03/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848453 | CMS |
| ABBVIE INC. | $17.72 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848455 | CMS |
| ABBVIE INC. | $9.83 | 08/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848457 | CMS |
| ABBVIE INC. | $7.04 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848459 | CMS |
| ABBVIE INC. | $11.59 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848461 | CMS |
| ABBVIE INC. | $11.53 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848463 | CMS |
| ABBVIE INC. | $12.75 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848465 | CMS |
| ABBVIE INC. | $76.17 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848467 | CMS |
| ABBVIE INC. | $7.28 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107848469 | CMS |
| Dermavant Sciences, Inc. | $51.97 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128005141 | CMS |
| Janssen Biotech, Inc. | $99.00 | 03/28/2024 | Education | Undisputed | 01/23/2026 | 1078821410 | CMS |
| Janssen Biotech, Inc. | $10.71 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078821513 | CMS |
| Janssen Biotech, Inc. | $9.98 | 11/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078821406 | CMS |
| Janssen Biotech, Inc. | $10.35 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078821501 | CMS |
| Janssen Biotech, Inc. | $7.56 | 12/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078821438 | CMS |
| Lilly USA, LLC | $94.55 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135508690 | CMS |
| UCB, Inc. | $78.02 | 04/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143216836 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.